Antibe Therapeutics Inc (ATE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2023 | 03-2022 | 03-2021 | 03-2020 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,755 | 34,807 | 71,973 | 6,182 | 5,993 |
| Marketable Securities | 32,137 | 20,000 | 25 | 25 | 25 |
| Receivables | 1,615 | 1,121 | 2,584 | 1,694 | 1,567 |
| Inventories | N/A | 0 | 2,157 | 3,424 | 2,803 |
| Other current assets | 0 | 4,632 | 0 | 0 | 0 |
| TOTAL | $41,546 | $61,364 | $79,103 | $11,507 | $10,564 |
| Non-Current Assets | |||||
| PPE Net | N/A | 0 | 309 | 303 | 181 |
| Investments And Advances | N/A | N/A | N/A | 0 | 100 |
| Intangibles | 26,352 | 26,352 | 869 | 1,771 | 3,717 |
| Other Non-Current Assets | 2,663 | 1,442 | 1,460 | 257 | 257 |
| TOTAL | $29,015 | $27,794 | $2,638 | $2,331 | $4,255 |
| Total Assets | $70,561 | $89,158 | $81,741 | $13,838 | $14,819 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,218 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 2,330 | N/A | N/A |
| Accrued Expenses | N/A | N/A | 1,278 | N/A | N/A |
| Other current liabilities | N/A | 1,878 | N/A | N/A | N/A |
| TOTAL | $2,764 | $4,694 | $3,741 | $7,595 | $2,907 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,072 |
| TOTAL | $27,631 | $27,631 | $27,736 | $2,464 | $4,472 |
| Total Liabilities | $30,395 | $32,325 | $31,477 | $10,059 | $7,378 |
| Shareholders' Equity | |||||
| Common Shares | 141,489 | 139,547 | 111,574 | 49,666 | 36,986 |
| Retained earnings | -130,491 | -111,016 | -85,956 | -59,673 | -40,332 |
| Other shareholders' equity | 10,264 | 10,264 | 10,353 | 2,644 | 2,752 |
| TOTAL | $40,166 | $56,833 | $50,264 | $3,779 | $7,441 |
| Total Liabilities And Equity | $70,561 | $89,158 | $81,741 | $13,838 | $14,819 |